Arcturus Therapeutics Holdings Inc
NASDAQ:ARCT
Arcturus Therapeutics Holdings Inc
Common Shares Outstanding
Arcturus Therapeutics Holdings Inc
Common Shares Outstanding Peer Comparison
Competitive Common Shares Outstanding Analysis
Latest Figures & CAGR of Competitors
Company | Common Shares Outstanding | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Arcturus Therapeutics Holdings Inc
NASDAQ:ARCT
|
Common Shares Outstanding
$26.9m
|
CAGR 3-Years
1%
|
CAGR 5-Years
20%
|
CAGR 10-Years
30%
|
|
Abbvie Inc
NYSE:ABBV
|
Common Shares Outstanding
$1.8B
|
CAGR 3-Years
0%
|
CAGR 5-Years
4%
|
CAGR 10-Years
1%
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Common Shares Outstanding
$1.2B
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
-2%
|
|
Amgen Inc
NASDAQ:AMGN
|
Common Shares Outstanding
$536.4m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-3%
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Common Shares Outstanding
$258.3m
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
1%
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Common Shares Outstanding
$110.2m
|
CAGR 3-Years
1%
|
CAGR 5-Years
0%
|
CAGR 10-Years
1%
|
See Also
What is Arcturus Therapeutics Holdings Inc's Common Shares Outstanding?
Common Shares Outstanding
26.9m
USD
Based on the financial report for Mar 31, 2024, Arcturus Therapeutics Holdings Inc's Common Shares Outstanding amounts to 26.9m USD.
What is Arcturus Therapeutics Holdings Inc's Common Shares Outstanding growth rate?
Common Shares Outstanding CAGR 10Y
30%
Over the last year, the Common Shares Outstanding growth was 1%. The average annual Common Shares Outstanding growth rates for Arcturus Therapeutics Holdings Inc have been 1% over the past three years , 20% over the past five years , and 30% over the past ten years .